Page 2 - Proteomics Facility News Today : Breaking News, Live Updates & Top Stories | Vimarsana

 E-Mail IMAGE: A preclinical study shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues. This technology, using... view more  Credit: MD Anderson Cancer Center Abstract #LB008 HOUSTON -- A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues. This technology,...

Date Time Positive signs of immunity after COVID-19 infection Australian scientists have described the evolution of immunity levels up to four months following COVID-19 infection, finding that while antibody levels drop dramatically in the first one to two months, the decrease then slows down substantially. The findings suggest that protective COVID-19 vaccines should ideally generate stronger antibody responses than natural infection. The research, led by Professor Stephen Kent from the Doherty Institute in collaboration with the University of New South Wales Kirby Institute and Flinders Uni...